HUBBARD CRISTIN (EVP, Chief Commercial Officer) received a stock award from BIOMARIN PHARMACEUTICAL INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/18/2026ACC: 0001628280-26-019269
Officer· EVP, Chief Commercial Officer
Since May 2024
+50.84K
Net shares
Net buyer
$69.8K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
52.09K acquired · 1.25K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15.41K
Price / share
—
Trade value
—
% of position
50.3%
3/16/2026
30.63K→46.03K
Common Stock
Direct
Shares
−1.25K
Price / share
$56.05
Trade value
$69.78K
% of position
2.7%
3/17/2026
46.03K→44.79K
Total
Net shares
+14.16K
Net value
-$69.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2026 | A · Award | +15.41K | — | — | 50.3% | 30.63K | 46.03K |
| Common Stock Direct | 3/17/2026 | F · Tax Withholding | −1.25K | $56.05 | $69.78K | 2.7% | 46.03K | 44.79K |
| Total | +14.16K | -$69.78K | ||||||
Derivative Transactions1
Stock Option (Right to Buy Common Stock)
Direct
Converts to
Common Stock
36.68K shares
Shares
+36.68K
Strike price
57.43
Held after
36.68K
Exercisable
—
3/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock) Direct | Common Stock36.68K shares | 3/16/2026 | A · Award | +36.68K | 57.43 | — | 36.68K |